Novo Nordisk, the manufacturer of Wegovy, offers a 7.2 mg dose to patients who do not benefit enough from the previous maximum dose of 2.4 mg
They recognize that clinical trials showed modest effects (average 2.6 kg over 12 weeks in responders), appreciate that individual response varies significantly, commit to proper nutrition and exercise foundations, and accept that the peptide is used for research purposes under medical supervision
But this does not fully offset the energy impact of losing lean tissue, especially if protein intake is inadequate and resistance training is absent
Ozempic: Mechanism of Action
The primary endpoints were the percentage change in body weight relative to baseline and the proportion of patients achieving a weight loss of 5% or more ( 4.11 SURMOUNT-CN: tirzepatide for weight loss in Chinese obese and overweight adults The SURMOUNT-CN trial recruited 210 obese or overweight adult patients in China, who received weekly doses of tirzepatide (10 mg, 15 mg) or placebo for 52 weeks
Unlike troches that dissolve slowly under the tongue, ODTs disintegrate quickly and allow for both buccal (cheek) and sublingual absorption
